Skip to content

Clinical trials

Achondroplasia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Achondroplasia Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20161
20181
20192
20202
20211
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Active, not recruiting2
Enrolling by invitation2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
QED Therapeutics, a BridgeBio company4
Ascendis Pharma A/S3
BioMarin Pharmaceutical2
Ascendis Pharma Growth Disorders A/S1
Hospices Civils de Lyon1
Pfizer1
SYSNAV1
Tyra Biosciences, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Achondroplasia14
Dwarfism7
Bone Diseases6
Genetic Diseases, Inborn4
Mucopolysaccharidosis IV4
Musculoskeletal Diseases4
Osteochondrodysplasias4
Bone Diseases, Developmental3

Trials

Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.